[Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000700:Analgesics; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry; D002110:Caffeine / Q000037:antagonists & inhibitors; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004357:Drug Synergism; D000431:Ethanol / Q000494:pharmacology; D000882:Haplorhini; D007210:Indoleacetic Acids / Q000652:urine; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D008774:Methylphenidate / Q000037:antagonists & inhibitors; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology; D010880:Piperidines / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D012640:Seizures / Q000139:chemically induced; D012701:Serotonin / Q000032:analysis; D014227:Triazines / Q000494:pharmacology*
D000700:Analgesics; D007210:Indoleacetic Acids; D010880:Piperidines; D014227:Triazines; D008774:Methylphenidate; D012701:Serotonin; D002110:Caffeine; D000431:Ethanol; D002707:Chlordiazepoxide; D009020:Morphine; D012110:Reserpine; D008620:Meprobamate; D000661:Amphetamine; D010424:Pentobarbital; D002746:Chlorpromazine